Latest Sourcefire, Inc. News and Updates
Cannabis Stocks Had a Mixed Performance Last Week
Cannabis ETFs traded on a largely negative note last week.
What Do Analysts Recommend for Supreme Cannabis?
Wall Street favors a “hold” rating for Supreme Cannabis. Four analysts recommend a ‘hold,’ three recommend a ‘buy,’ and one recommends a ‘sell.’
Cannabis Sector Marks Third Straight Day of Decline
The downward momentum in cannabis stocks has continued today, marking the third straight day of decline for the cannabis sector.
Has Supreme Cannabis’s Stock Price Bottomed Out?
As of December 24, Supreme Cannabis was trading at 0.66 Canadian dollars. The company has lost 50% of its stock value this year. Has its stock bottomed out?
Supreme Cannabis: Lower Target Price after Q1 Earnings
Following Supreme Cannabis’s weak first-quarter performance, PI Financial and Canaccord Genuity lowered their target prices.
Cannabis Stocks: Canaccord Updates Target Prices
For Aurora Cannabis (ACB), Canaccord lowered its target price from 13.50 Canadian dollars to 8.00 Canadian dollars with a “speculative buy” rating.
Cannabis Sector: Week Ended October 10 in Review
The cannabis sector continued its downward movement in the week that ended on October 10, with ETFs and prominent cannabis players falling.
Cannabis Sector: The Week in Review for October 3
The cannabis sector was trading in the red for the week ended October 3. The sector’s ETFs broadly ended the week in negative territory.
Supreme Cannabis: Analysts’ Target Price and Ratings
Supreme Cannabis (FIRE) reported its fourth-quarter earnings on September 17. The company reported revenue growth of 90% from its third-quarter revenues.
Cannabis Roundup on FIRE, ACB, CGC, and TLRY
Cannabis stocks mostly traded in positive territory today. Supreme Cannabis (FIRE) and Aurora Cannabis (ACB) rose about 9.5% and 5.5%, respectively.
Key Cannabis Sector Updates: Analyst Ratings and Earnings
Last week, Emerald Health Therapeutics (EMH) closed with losses of 9.4%.